Keefe, Bruyette & Woods lowered shares of HIVE Blockchain Technologies (CVE:HIV – Free Report) from a moderate buy rating to a hold rating in a report released on Tuesday morning,Zacks.com reports.
Separately, B. Riley raised HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Friday, November 21st. Two research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy”.
Get Our Latest Stock Report on HIV
HIVE Blockchain Technologies Price Performance
See Also
- Five stocks we like better than HIVE Blockchain Technologies
- What a Former CIA Agent Knows About the Coming Collapse
- Inside: Pre-IPO Ticker + The Next Elon Musk?
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Buy this Gold Stock Before May 2026
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
